Disease manifestations in the systemic microcirculation of children
A retrospective analysis illuminates discrepancies between adult and paediatric cataract procedures around the globe
Examining the anatomy and physiology may prevent ineffective stent implantation.
Surgeon discusses latest trends for treating cornea
Restoration and regeneration represent a new paradigm
Why “acceleration” is the industry keyword for 2024
Long-term treatment helps chronic, vision-threatening disease.
The investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age
A UK health data research hub containing vast numbers of fundus and OCT images opens the door to improved screening and diagnoses of eye diseases and even ‘oculomic’ services for systemic health.
A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
The CRL comes in response to a supplemental New Drug Application for Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration
A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis
A new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.
Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Newly developed acrylic implant provides option for patients with endothelial dysfunction.
An AI-supported telemedicine effort from Siloam Vision and Orbis International
For ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.
Patients who received digital education demonstrated a better understanding of their disease and its management
Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Computer software platform provides home vision exercises to overcome asthenopia.
New analysis brings disease progression and therapeutics into focus
In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma
In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Recent reports of retinal atrophy have raised concerns on potential long-term safety.